GL1X · GenesisL1 explorer

MolNFT v1 · #94581 · protein

Structure-based design of novel dihydroisoquinoline bace-1 inhibitors that do not engage the catalytic aspartates

4I10 · Beta-secretase 1: “Structure-based design of novel dihydroisoquinoline bace-1 inhibitors that do not engage the catalytic…”. X-ray diffraction, 2 ligands (1BS, ZN), 3 pockets (best druggability 0.69). MolNFT v1 #94581 on GenesisL1…

PDB
4I10
Type
protein
Length
390 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-secretase 1
EC
3.4.23.46
UniProt
P56817
Ligands
1BS, ZN
Pockets
3 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-secretase 1 (EC 3.4.23.46)protein39014% helix, 41% strandP56817

Ligands and binding sites

  • 1BS · 2-{(1S)-1-[(6-chloro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)amino]-2-phenylethyl}pyrido[4,3-d]pyrimidin-4(1H)-one · ligand · chains A
  • ZN · Zinc ion · metal · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15290.690.79491BS
21600.500.7827empty
3550.340.7817empty

Modifications

Observed in the structure: 3 disulfide (disulfide).

Compared structures

  • 4I10 · Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage… · the same entry in another collection · chain A against A, TM-score 1.00
  • P56817 · AlphaFold monomer V2.0 prediction for beta-secretase 1 (P56817) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.